| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Is Your System Leading You To Problems? |
|
Advice You - Is Your System Leading You To Problems?
Any organization has a system to operate it efficiently. But if your system itself leads you to problems, what can yo According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product u do? Yes it is true. Many organizations have systems which lead them to problems. Good example is the communication ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in process in your organization. How many people involved in this channel of communication. In most of the cases many i lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. sn’t it. Longer the length of this communication channel greater the error it can create. It is interesting to see wh here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe there is a longer channel length. One reason maybe to keep all the parties informed. But in many cases this is to re d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro flect the organizational hierarchy in the process of communication. Another good example is data duplication. Data d ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc uplication does not add any value to your system. But map your data process and see how many duplications your system easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi has. I am sure you will be surprised. In this age of information I really do not see a requirement to duplicate data nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically entry. Again it is interesting to see why these data duplication occur in an organization. According to my experience and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ this is to create variety of reports and point fingers at other departments and people. It may seem like exaggerated ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi But this is true. Many data entry points are useless for the functionality of the organization. Therefore these are ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a unnecessary activities which will eventually reduce the efficiency of the organization. These activities do not add v dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod alue to your end product or at least does not help that purpose. Even worst these activities can give you wrong infor cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin mation and lead to wrong decisions. Remember in every point of duplication there is a possibility of introducing erro tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen s. I believe these are familiar to you if you are already working in a non lean manufacturing environment. In lean m t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel anufacturing environments though, there is a concept called mistake proofing or pokayoke. Aim of pokayoke is to creat ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e a system which is error proofed itself. The first step may be to implement 5S in your working place. This will avoi y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products many mistakes in work. Analyze your system further and refine it continuously so that it will be more and more towar . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ds a mistake proofed system. When you implement pokayoke correctly you will see one very important fact about mistake elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip s. You will understand that people do not make mistakes willingly and the system is what guides them towards mistakes tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:America's Great Advantage Creating Divergent Industries Be Prepared for Any Interview Question
|